The EVA spectral descriptor

European Journal of Medicinal Chemistry

Volumn 35, Issue 4, 2000, Pages 367-375

  Turner, David B ^a   Willett, Peter ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

3 D QSAR; Alignment free; Descriptor sampling; GA; IR Raman vibration; PLS

Indexed keywords

CALCULATION; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; INFRARED SPECTROMETRY; MOLECULAR DYNAMICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAMAN SPECTROMETRY; REVIEW; STRUCTURE ANALYSIS;

EID: 0034043630     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00141-0     Document Type: Review

References (44)

1. Cramer R.D., Patterson D.E., Bunce J.D. J. Am. Chem. Soc. 110:1988;5959-5967.
2. Oprea T.I., Waller C.L. Theoretical and practical aspects of three-dimensional quantitative structure-activity relationships. Lipkowitz K.B, Boyd D.B. Reviews in Computational Chemistry Vol. 11. 1997;Wiley-VCH, NY.
3. Kellogg G.E., Semus S.F., Abraham D.J. J. Comput.-Aided Mol. Des. 5:1991;545-552.
4. Carrupt P.A., Gaillard P., Billois F., Weber P.C., Testa B., Meyer C., Perez S. Lipophilicity in drug action and toxicology. Pliska V, Testa B, van de Waterbeemd H. Methods and Principles in Medicinal Chemistry Vol. 4. 1996;195-217 VCH Publishers, Weinheim.
5. Hansch C., Fujita T. J. Am. Chem. Soc. 86:1964;1616-1626.
6. Hansch C., Leo A. Exploring QSAR. Fundamentals and Applications in Chemistry and Biology. ACS Professional Reference Book. 1995;American Chemical Society, Washington DC.
7. Cruciani G., Clementi S. van de Waterbeemd H. Methods and Principles in Medicinal Chemistry Vol. 3, Advanced Computer-Assisted Techniques in Drug Discovery. 1995;61-88 VCH, Weinheim.
8. Goodford P. J. Chemom. 10:1996;107-117.
9. Klebe G., Abraham U., Mietzner T. J. Med. Chem. 37:1994;4130-4146.
10. Kubinyi H. 3-D QSAR in Drug Design. 1993;ESCOM, Leiden.
11. Cho S.J., Tropsha A. J. Med. Chem. 38:1995;1060-1066.
12. Kroemer R.T., Hecht P. J. Comput.-Aided Mol. Des. 9:1995;205-212.
13. Kroemer R.T., Hecht P. J. Comput.-Aided Mol. Des. 9:1995;396-406.
14. Silverman B.D., Platt D.E. J. Med. Chem. 39:1996;2129-2140.
15. Muresan S., Sulea T., Ciubotariu D., Kurunczi L., Simon Z. Quant. Struct.-Act. Relat. 15:1996;31-32.
16. Wagener M., Sadowski J., Gasteiger J. J. Am. Chem. Soc. 117:1995;7769-7775.
17. Todeschini R., Vighi M., Provenzani R., Finizio A., Gramatica P. Chemosphere. 32:1996;1527-1545.
18. Jonathan P., McCarthy W.V., Roberts A.M.I. J. Chemom. 10:1996;189-214.
19. Ferguson A.M., Heritage T., Pack S.E., Phillips L., Rogan J., Snaith P.J. J. Comput.-Aided Mol. Des. 11:1997;143-152.
20. Turner D.B., Willett P., Ferguson A.M., Heritage T. J. Comput.-Aided Mol. Des. 11:1997;409-422.
21. Turner D.B., Willett P., Ferguson A.M., Heritage T. J. Comput.-Aided Mol. Des. 13:1999;271-296.
22. Turner D.B., Willett P. J. Comput.-Aided Mol. Des. 14:2000;1-21.
23. Ginn C.M.R., Turner D.B., Willett P., Ferguson A.M., Heritage T.W. J. Chem. Inf. Comput. Sci. 37:1997;23-37.
24. Scott A.P., Radom L. J. Phys. Chem. 100:1996;16502-16513.
25. Wold S., Ruhe A., Wold H., Dunn III W.J. SIAM J. Sci. Stat. Comput. 5:1984;735-743.
26. Coats E.A. Kubinyi H, Folkers G, Martin Y.C. 3-D QSAR in Drug Design: Recent Advances. Perspectives in Drug Discovery and Design Vols. 12/13/14. 1998;199-213 Kluwer/ESCOM, Dordrecht.
27. Sicsic S., Serraz I., Andrieux J., Brémont B., Mathé-Allainmat M., Poncet A., Shen S., Langlois M. J. Med. Chem. 40:1997;739-748.
28. Cho S.J., Tropsha A. J. Med. Chem. 38:1995;1060-1066.
29. Turner D.B., PhD Thesis (1996) Sheffield University, UK.
30. Shapiro S., Guggenheim B. Quant. Struct.-Act. Relat. 17:1998;327-337.
31. Shapiro S., Guggenheim B. Quant. Struct.-Act. Relat. 17:1998;338-347.
32. Patterson D.E., Cramer III R.D., Ferguson A.M., Clark R.D., Weinberger L.E. J. Med. Chem. 39:1996;3049-3059.
33. Clark R.D., Brusati M., Jilek R., Heritage T., Cramer R.D. Validating QSAR descriptors for use in diversity analysis. Gundertofte K, Jorgensen F.S. Molecular Modelling and Prediction of Bioactivity. 2000;Plenum Press, NY. in press.
34. UNITY is available from Tripos Inc. at: http://www.tripos.com/.
35. MM3 (94) Manual (Version 1.0). Tripos Associates Inc., 1699 South Hanley Road, St. Louis, MO 63144, USA. This contains numerous references to the MMx series of programs developed by Norman Allinger and co-workers at the University of Georgia.
36. Stone M., Brooks R.J. J. Royal Stat. Soc. Series B - Methodological. 52:1990;237-269.
37. Cruciani G., Clementi S. van de Waterbeemd H. Methods and Principles in Medicinal Chemistry Vol. 3, Advanced Computer-Assisted Techniques in Drug Discovery. 1995;61-88 VCH, Weinheim.
38. Lindgren F., Geladi P., Rannar S., Wold S. J. Chemom. 8:1994;349-363.
39. Clementi S., Wold S. van de Waterbeemd H. Methods and Principles in Medicinal Chemistry Vol. 2, Chemometric Methods in Molecular Design. 1993;319-338 VCH, Weinheim.
40. Heritage T.J., Ferguson A.M., Turner D.B., Willett P. Kubiny H. 3-D QSAR in Drug Design Vol. 2. 2000;381-398 ESCOM, Leiden.
41. Bursi R., Dao T., Van Wijk T., de Gooyer M., Kellenbach E., Verwer P. J. Chem. Inf. Comp. Sci. 39:1999;861-867.
42. Tuppurainen K. SAR and QSAR in Environ. Res. 10:1999;39-46.
43. Winn M., von Geldern T.W., Opgenorth T.J., Jae H.S., Tasker A.S., Boyd S.A., et al. J. Med. Chem. 39:1996;1039-1048.
44. Krystek S.R., Hunt J.T., Stein P.D., Stouch T.R. J. Med. Chem. 38:1995;659-668.